Chemoimmunotherapy with inotuzumab ozogamicin combined with mini-hyper-CVD, with or without blinatumomab, is highly effective in patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first salvage (Q57279955)
Jump to navigation
Jump to search
scientific article published on 11 October 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Chemoimmunotherapy with inotuzumab ozogamicin combined with mini-hyper-CVD, with or without blinatumomab, is highly effective in patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first salvage |
scientific article published on 11 October 2018 |
Statements
Chemoimmunotherapy with inotuzumab ozogamicin combined with mini-hyper-CVD, with or without blinatumomab, is highly effective in patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first salvage (English)
Joseph Khoury
Nicholas J Short
Marina Konopleva
Rebecca Garris
Maria Khouri
Jeffrey Jorgensen
Partow Kebriaei
Xuelin Huang
Jovitta Jacob
Guillermo Garcia-Manero
Susan O'Brien
Nitin Jain
Kathryn Montalbano
Farhad Ravandi
11 October 2018